Medication commonly prescribed for prostate issues has been linked to an increased risk of developing type 2 diabetes in the men who take them.
The study joins past research that found these drugs may decrease insulin sensitivity in patients, an early warning sign that the individual may eventually develop type 2 diabetes.
However, the team behind the latest research warns that patients shouldn’t stop taking their medication — rather, the data reveals that patients should ensure they’re properly screened for the condition.
Prostate medications work by reducing the patient’s androgen levels, causing the prostate to shrink and improving symptoms.
That’s a good thing for patients suffering from related conditions, but bad news if it results in the development of type 2 diabetes, which is itself a serious disease.
Patients shouldn’t stop taking their medication, the researchers warn.